血液与组织嗜酸粒细胞同时增多与鼻息肉疾病控制不良相关
该回顾性研究纳入183例术后至少1年的鼻息肉患者,按血液和组织嗜酸粒细胞水平分为4组,以EPOS 2012标准评估疾病控制。多重Logistic回归显示血液嗜酸粒细胞计数和组织嗜酸粒细胞百分比均独立与疾病控制不良风险增加相关,且两者同时增多者风险高于单一增多者。
要点
- 血嗜酸粒细胞计数和组织嗜酸粒细胞百分比均独立与鼻息肉控制不良风险增加相关。
- 血液与组织嗜酸粒细胞同时增多的患者控制不良风险高于仅血液或仅组织增多者。
- 无嗜酸粒细胞炎症组占比最高(41.5%),同时增多组次之(31.2%)。
核心结论
- 在校正潜在混杂因素后,血液与组织嗜酸粒细胞同时增多的鼻息肉患者术后疾病控制不良风险高于仅血液或仅组织嗜酸粒细胞增多者。
研究设计与样本
- 回顾性分析183例慢性鼻窦炎伴鼻息肉并行内镜鼻窦手术且术后至少1年的患者,按EPOS 2012标准评估疾病控制。
主要发现
- BT-low组患者比例最高为41.5%,BT-high组次之为31.2%,T-high组为15.3%,B-high组为12.0%。
- 多重Logistic回归显示外周血嗜酸粒细胞数量和组织嗜酸粒细胞百分比均独立与疾病控制不良风险增加相关。
- BT-high组患者术后病情控制不良风险高于B-high和T-high组。
关键数值与推荐
- 分组阈值:外周血嗜酸粒细胞0.3×10^9/L,组织嗜酸粒细胞10%。
- 疾病控制评估依据EPOS 2012标准。
临床怎么用
- 对鼻息肉患者可同时评估外周血嗜酸粒细胞计数和组织嗜酸粒细胞百分比,以识别术后控制不良高危人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore whether blood and polyp tissue eosinophil numbers are independent risk factors for poor disease control in patients with nasal polyp. Methods: By using the electronic medical records database and manual evaluation, 183 nasal polyp patients who had undergone endoscopic sinus surgery at least one year prior to the study with complete data of tissue specimens, baseline blood routine test, nasal endoscopy and sinus computed tomography, were identified and recruited to assess disease control based on the criteria of a European Position Paper on Rhinosinusitis and Nasal Polyps 2012 (EPOS 2012). Multiple logistic regression model was used to determine the association between blood and tissue eosinophil numbers and risk of poor disease control by adjusting for demographics and comorbidities. Results: We broke down the cohort into 4 groups according to blood (0.3×109/L) and tissue (10%) eosinophils. The patients without eosinophilic inflammation represented the largest group (41.5%). The group with concordant blood and tissue eosinophilia represented the second largest (31.2%), and the patients with isolated tissue (15.3%) or blood (12.0%) eosinophilia were relatively rare. Multiple logistic regression models found blood eosinophil count and tissue eosinophil percentage were independently associated with increased risk for poor disease control after adjustments for covariates related to poor treatment outcome. Furthermore, subjects with concordant blood and tissue eosinophilia had a higher risk for poor disease control than those with isolated blood or tissue eosinophilia. Conclusion: Concordant blood and tissue eosinophilia relates to a higher likelihood of poor disease control than isolated blood or tissue eosinophilia after adjustment of potential confounders in nasal polyp patients. 目的: 探讨外周血和鼻息肉组织中嗜酸粒细胞增多是否为鼻息肉治疗预后不佳的独立危险因素。 方法: 回顾性分析2015年1月至2017年12月在中山大学附属第一医院耳鼻咽喉科医院诊断为慢性鼻窦炎伴鼻息肉(CRSwNP)并行内镜鼻窦手术,且术后至少1年以上的183例患者的病例资料,并按照欧洲鼻窦炎和鼻息肉意见书(EPOS)2012对所有病例进行疾病临床控制程度的评估。在校正一般的以及合并症的混杂因素后,采用多重Logistic回归模型分析外周血和组织嗜酸粒细胞数量与病情控制不良风险之间的关联性。 结果: 根据外周血和组织嗜酸粒细胞是否增多将病例分为4组:同时伴有外周血和组织嗜酸粒细胞增多的鼻息肉为BT-high组,仅伴有外周血嗜酸粒细胞增多的鼻息肉为B-high组,仅伴有组织嗜酸粒细胞增多的鼻息肉为T-high组,不伴外周血和组织嗜酸粒细胞增多的鼻息肉为BT-low组。其中BT-low组的患者比例最高,达到了41.5%;BT-high组的病例次之,占31.2%;而T-high组和B-high组的患者比例相对较低,分别为15.3%和12.0%。在校正了混杂因素后,多重Logistic回归模型分析发现外周血嗜酸粒细胞数量和组织嗜酸粒细胞百分比与病情控制不良的风险增加独立相关。此外,相比于B-high和T-high组的患者,BT-high组的患者具有更高的术后病情控制不良风险。 结论: 系统性和局部性嗜酸粒细胞同时增多的鼻息肉患者,术后病情控制不良的风险显著高于仅伴有外周血或组织嗜酸粒细胞增多者。.
引用
- Wang KH, Deng J, Yang M, et al. [Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021. PMID: 34666464. doi:10.3760/cma.j.cn115330-20210428-00235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。